Second opinions can save lives, especially when it comes to cancer. Dr. Schapira covers the ins and outs of second (and third and fourth) opinions.

Immunotherapy made exciting strides in 2015. Because of its potential, ASCO named it the 2016 Clinical Cancer Advance of the Year.

In this video, Jyoti Patel, MD, discusses the common side effects that come with chemotherapy and some practical advice for talking with your health care team.

Susan Cohn, MD, shares a personal story about the courage of parents who enrolled their child in a clinical trial for a drug that is now approved to treat neuroblastoma.

When Randy Hillard was diagnosed with metastatic stomach cancer in 2010 he was treated with a drug that increased overall survival to an average of 13 months. Now, nearly 5 years later, his unexpected survival has led to some unexpected issues.

Edward S. Kim, MD, FACP, shares new approaches to molecular medicine that are helping doctors to better treat patients with cancer.

In this podcast, Leslie R. Schover, PhD, discusses the sexual concerns that often come with hormone therapy for prostate cancer.

Cancer and cancer treatments often weaken the immune system, making it harder for the body to protect itself from foodborne illness. So how can you stay food safe? This infographic produced by Cancer.Net and the USDA Food Safety and Inspection Service can help.

In March 2013, John’s wife Lori found a lump in her breast. Lori, a radiation oncologist, soon went from giving cancer care to receiving it. In this guest post, John talks about how to navigate a cancer diagnosis, a journey for which we are all ill-prepared.

In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future.